Goeken N E
Hum Immunol. 1984 Aug;10(4):251-63. doi: 10.1016/0198-8859(84)90090-9.
In these investigations, human lymphocytes primed in vitro in MLR have been employed as a model for human memory cells and have been compared to naive lymphocytes from the same donor. Both the stimulatory requirements and the regulation of these cells were found to differ significantly. The dose of stimulators giving a maximal primary (I) response was less than 10% the dose of restimulating cells giving a maximal secondary (II) response. II responses were further found to be inversely related to the original I response. This was associated with at least two separate regulatory phenomena. Suppressor cell induction was enhanced at high priming doses while memory cell precursors were preferentially stimulated at very low priming doses. Priming of memory cells could also be demonstrated to occur in the absence of any detectable I proliferation by utilizing platelets or heat treated stimulators. Memory cells were also a much more resistant than naive cells to both alloantigen induced suppressor cells and to culture activated monocyte suppressor cells. This in vitro model suggests that the human I and II responses to alloantigen have both distinct triggering requirements and differential sensitivity to regulatory cells. It is suggested that preferential formation of memory cells under conditions that require no proliferation and which are suboptimal for suppressor cell generation and the acquired resistance of memory cells to down regulation by suppressor cells may contribute to the poor graft prognosis of sensitized renal transplant patients.
在这些研究中,体外混合淋巴细胞反应(MLR)中致敏的人淋巴细胞已被用作人类记忆细胞的模型,并与来自同一供体的未致敏淋巴细胞进行了比较。发现这些细胞的刺激需求和调节存在显著差异。产生最大初次(I)反应的刺激剂剂量不到产生最大二次(II)反应的再刺激细胞剂量的10%。进一步发现II反应与原始I反应呈负相关。这与至少两种独立的调节现象有关。在高致敏剂量下抑制细胞诱导增强,而记忆细胞前体在极低致敏剂量下优先受到刺激。通过使用血小板或热处理的刺激剂,还可以证明在没有任何可检测到的I增殖的情况下也会发生记忆细胞的致敏。记忆细胞对同种异体抗原诱导的抑制细胞和培养活化的单核细胞抑制细胞也比未致敏细胞更具抗性。这个体外模型表明,人类对同种异体抗原的I和II反应既有不同的触发需求,对调节细胞也有不同的敏感性。有人提出,在不需要增殖且对抑制细胞产生次优的条件下记忆细胞的优先形成以及记忆细胞对抑制细胞下调的获得性抗性可能导致致敏肾移植患者移植预后不良。